Eugenio Battaglia

Eugenio Battaglia

Oct 04, 2014

Group 6 Copy 105
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Affordable 3D-Printed Neural Devices for Spinal Cord Regeneration

    Medical treatments for spinal cord injuries are expensive and difficult to test. I want to try to develop...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Open Insulin

    A team of biohackers is developing the first open source protocol to produce insulin simply and economically...

    Backer Badge Funded